| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06d114257182ee7efd4c696c5fdb836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e071d18fea054bf8d1420d483e78ed1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6925
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2009-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_742cea8d0ba123b74b0d31da8c9bc6e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b42b5ad6662e4991dd081e76eb7ce98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_947382d9e54c66b19670d9e4515d4869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de34089d57df4f3d0e5018c866db11f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5517e43bc1fc20012ca73b695b33fb27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21f12df560705f313093a331a219512c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8470a13b2762e37fcc5ccccf12745ced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36810907bcc26933a000c7a3599cc78a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ffca2f8b0cac00d7a5118af9360fd60 |
| publicationDate |
2013-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2009303344-B2 |
| titleOfInvention |
Targeting of antigen presenting cells with immunonanotherapeutics |
| abstract |
The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides nanocarriers capable of stimulating an immuse response in T cells and/or in B cells. The invention provides nanocarriers that comprise an immunofeature surface. The nanocarriers are capable of targeting antigen presenting cells when administered to a subject. The invention provides pharmaceutical compositions comprising nanocarriers. The present invention provides methods of designing, manufacturing, and using nanocarriers and pharmaceutical compositions thereof. |
| priorityDate |
2008-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |